L Sourander

发表

GI motility disorders: diagnostic workup and use of prokinetic therapy.

I. Räihä, L. Sourander, I Räihä, 1993, Geriatrics.

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study

K. Blennow, B. Winblad, E. Vanmechelen, 1998, Journal of neurology, neurosurgery, and psychiatry.